|
| | BYAKANGELICIN Basic information |
| Product Name: | BYAKANGELICIN | | Synonyms: | Biacangelicin;Bjacangelicin;Bjakangelicin;Byankagelicine;9-[(2R)-2,3-dihydroxy-3-methyl-butoxy]-4-methoxy-furo[3,2-g]chromen-7-one;9-[(2R)-2,3-dihydroxy-3-methylbutoxy]-4-methoxyfuro[3,2-g]chromen-7-one;BYAKANGELICIN (P);5-Methoxy-8-(2,3-dihydroxy-3-methylbutoxy)psoralene | | CAS: | 482-25-7 | | MF: | C17H18O7 | | MW: | 334.32 | | EINECS: | | | Product Categories: | | | Mol File: | 482-25-7.mol |  |
| | BYAKANGELICIN Chemical Properties |
| Melting point | 123-124℃ | | Boiling point | 571.5±50.0 °C(Predicted) | | density | 1.373 | | storage temp. | Sealed in dry,Store in freezer, under -20°C | | solubility | Chloroform (Slightly), Methanol (Slightly) | | pka | 13.67±0.20(Predicted) | | form | neat | | color | Off-White to Light Yellow |
| Hazard Codes | Xn | | Risk Statements | 22-36/37/38 | | Safety Statements | 26 | | WGK Germany | 3 |
| | BYAKANGELICIN Usage And Synthesis |
| Uses | (+)-Byakangelicin is an effective inhibitor of sex hormones and affects the catabolism of endogenous hormones. It directly affects the cytochrome P450 isoform (CY) P3A4 in human hepatocytes. Also, an inhibitor of aldose reductase and used in the treatment of diabetic cataract. | | Definition | ChEBI: Byakangelicin is a member of psoralens. |
| | BYAKANGELICIN Preparation Products And Raw materials |
|
